Literature DB >> 19165914

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer.

Jiyoung Ahn, Sonja I Berndt, Sholom Wacholder, Peter Kraft, Adam S Kibel, Meredith Yeager, Demetrius Albanes, Edward Giovannucci, Meir J Stampfer, Jarmo Virtamo, Michael J Thun, Heather Spencer Feigelson, Geraldine Cancel-Tassin, Olivier Cussenot, Gilles Thomas, David J Hunter, Joseph F Fraumeni, Robert N Hoover, Stephen J Chanock, Richard B Hayes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19165914      PMCID： PMC3086200          DOI： 10.1038/ng0908-1032

Source DB:  PubMed          Journal:  Nat Genet        ISSN： 1061-4036            Impact factor:   38.330


× No keyword cloud information.
  12 in total

1.  Tagging SNPs in the kallikrein genes 3 and 2 on 19q13 and their associations with prostate cancer in men of European origin.

Authors:  Prodipto Pal; Huifeng Xi; Guangyun Sun; Ritesh Kaushal; Joshua J Meeks; C Shad Thaxton; Saurav Guha; Carol H Jin; Brian K Suarez; William J Catalona; Ranjan Deka
Journal:  Hum Genet       Date:  2007-06-26       Impact factor: 4.132

2.  Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study.

Authors:  Joseph C Presti; Gerard J O'Dowd; M Craig Miller; Rubina Mattu; Robert W Veltri
Journal:  J Urol       Date:  2003-01       Impact factor: 7.450

Review 3.  Screening for prostate cancer with prostate-specific antigen. An examination of the evidence.

Authors:  S H Woolf
Journal:  N Engl J Med       Date:  1995-11-23       Impact factor: 91.245

4.  Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Authors:  P C Prorok; G L Andriole; R S Bresalier; S S Buys; D Chia; E D Crawford; R Fogel; E P Gelmann; F Gilbert; M A Hasson; R B Hayes; C C Johnson; J S Mandel; A Oberman; B O'Brien; M M Oken; S Rafla; D Reding; W Rutt; J L Weissfeld; L Yokochi; J K Gohagan
Journal:  Control Clin Trials       Date:  2000-12

5.  PSA/KLK3 AREI promoter polymorphism alters androgen receptor binding and is associated with prostate cancer susceptibility.

Authors:  John Lai; Mary-Anne Kedda; Kimberly Hinze; Robert L G Smith; John Yaxley; Amanda B Spurdle; C Phillip Morris; Jonathan Harris; Judith A Clements
Journal:  Carcinogenesis       Date:  2006-12-06       Impact factor: 4.944

6.  Association between genetic polymorphisms in the prostate-specific antigen gene promoter and serum prostate-specific antigen levels.

Authors:  Scott D Cramer; Bao-Li Chang; Anuradha Rao; Gregory A Hawkins; S Lilly Zheng; Wendy N Wade; Roger T Cooke; Leanne N Thomas; Eugene R Bleecker; William J Catalona; David A Sterling; Deborah A Meyers; Jill Ohar; Jianfeng Xu
Journal:  J Natl Cancer Inst       Date:  2003-07-16       Impact factor: 13.506

Review 7.  Human tissue kallikreins: physiologic roles and applications in cancer.

Authors:  Carla A Borgoño; Iacovos P Michael; Eleftherios P Diamandis
Journal:  Mol Cancer Res       Date:  2004-05       Impact factor: 5.852

8.  Overdiagnosis due to prostate-specific antigen screening: lessons from U.S. prostate cancer incidence trends.

Authors:  Ruth Etzioni; David F Penson; Julie M Legler; Dante di Tommaso; Rob Boer; Peter H Gann; Eric J Feuer
Journal:  J Natl Cancer Inst       Date:  2002-07-03       Impact factor: 13.506

9.  Lead times and overdetection due to prostate-specific antigen screening: estimates from the European Randomized Study of Screening for Prostate Cancer.

Authors:  Gerrit Draisma; Rob Boer; Suzie J Otto; Ingrid W van der Cruijsen; Ronald A M Damhuis; Fritz H Schröder; Harry J de Koning
Journal:  J Natl Cancer Inst       Date:  2003-06-18       Impact factor: 13.506

10.  Single nucleotide polymorphism of the human kallikrein-2 gene highly correlates with serum human kallikrein-2 levels and in combination enhances prostate cancer detection.

Authors:  Robert K Nam; William W Zhang; John Trachtenberg; Eleftherios Diamandis; Ants Toi; Marjan Emami; Minnie Ho; Joan Sweet; Andrew Evans; Michael A S Jewett; Steven A Narod
Journal:  J Clin Oncol       Date:  2003-06-15       Impact factor: 44.544
View more
  48 in total

1.  eQTL mapping identifies insertion- and deletion-specific eQTLs in multiple tissues.

Authors:  Jinyan Huang; Jun Chen; Jorge Esparza; Jun Ding; James T Elder; Goncalo R Abecasis; Young-Ae Lee; G Mark Lathrop; Miriam F Moffatt; William O C Cookson; Liming Liang
Journal:  Nat Commun       Date:  2015-05-08       Impact factor: 14.919

2.  Utility of genome-wide association study findings: prostate cancer as a translational research paradigm.

Authors:  A R Turner; A K Kader; J Xu
Journal:  J Intern Med       Date:  2012-04       Impact factor: 8.989

3.  Comparison of two methods for estimating absolute risk of prostate cancer based on single nucleotide polymorphisms and family history.

Authors:  Fang-Chi Hsu; Jielin Sun; Yi Zhu; Seong-Tae Kim; Tao Jin; Zheng Zhang; Fredrik Wiklund; A Karim Kader; S Lilly Zheng; William Isaacs; Henrik Grönberg; Jianfeng Xu
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-03-23       Impact factor: 4.254

Review 4.  Identification of new genetic risk factors for prostate cancer.

Authors:  Michelle Guy; Zsofia Kote-Jarai; Graham G Giles; Ali Amin Al Olama; Sarah K Jugurnauth; Shani Mulholland; Daniel A Leongamornlert; Stephen M Edwards; Jonathan Morrison; Helen I Field; Melissa C Southey; Gianluca Severi; Jenny L Donovan; Freddie C Hamdy; David P Dearnaley; Kenneth R Muir; Charmaine Smith; Melisa Bagnato; Audrey T Ardern-Jones; Amanda L Hall; Lynne T O'Brien; Beatrice N Gehr-Swain; Rosemary A Wilkinson; Angela Cox; Sarah Lewis; Paul M Brown; Sameer G Jhavar; Malgorzata Tymrakiewicz; Artitaya Lophatananon; Sarah L Bryant; Alan Horwich; Robert A Huddart; Vincent S Khoo; Christopher C Parker; Christopher J Woodhouse; Alan Thompson; Tim Christmas; Chris Ogden; Cyril Fisher; Charles Jameson; Colin S Cooper; Dallas R English; John L Hopper; David E Neal; Douglas F Easton; Rosalind A Eeles
Journal:  Asian J Androl       Date:  2008-12-01       Impact factor: 3.285

5.  Estimation of absolute risk for prostate cancer using genetic markers and family history.

Authors:  Jianfeng Xu; Jielin Sun; A Karim Kader; Sara Lindström; Fredrik Wiklund; Fang-Chi Hsu; Jan-Erik Johansson; S Lilly Zheng; Gilles Thomas; Richard B Hayes; Peter Kraft; David J Hunter; Stephen J Chanock; William B Isaacs; Henrik Grönberg
Journal:  Prostate       Date:  2009-10-01       Impact factor: 4.104

6.  Variation in genes involved in the immune response and prostate cancer risk in the placebo arm of the Prostate Cancer Prevention Trial.

Authors:  Danyelle A Winchester; Cathee Till; Phyllis J Goodman; Catherine M Tangen; Regina M Santella; Teresa L Johnson-Pais; Robin J Leach; Jianfeng Xu; S Lilly Zheng; Ian M Thompson; M Scott Lucia; Scott M Lippmann; Howard L Parnes; Paul J Dluzniewski; William B Isaacs; Angelo M De Marzo; Charles G Drake; Elizabeth A Platz
Journal:  Prostate       Date:  2015-06-05       Impact factor: 4.104

7.  A large multiethnic genome-wide association study of prostate cancer identifies novel risk variants and substantial ethnic differences.

Authors:  Thomas J Hoffmann; Stephen K Van Den Eeden; Lori C Sakoda; Eric Jorgenson; Laurel A Habel; Rebecca E Graff; Michael N Passarelli; Clinton L Cario; Nima C Emami; Chun R Chao; Nirupa R Ghai; Jun Shan; Dilrini K Ranatunga; Charles P Quesenberry; David Aaronson; Joseph Presti; Zhaoming Wang; Sonja I Berndt; Stephen J Chanock; Shannon K McDonnell; Amy J French; Daniel J Schaid; Stephen N Thibodeau; Qiyuan Li; Matthew L Freedman; Kathryn L Penney; Lorelei A Mucci; Christopher A Haiman; Brian E Henderson; Daniela Seminara; Mark N Kvale; Pui-Yan Kwok; Catherine Schaefer; Neil Risch; John S Witte
Journal:  Cancer Discov       Date:  2015-06-01       Impact factor: 39.397

8.  Intermediacy and gene-environment interaction: the example of CHRNA5-A3 region, smoking, nicotine dependence, and lung cancer.

Authors:  Sholom Wacholder; Nilanjan Chatterjee; Neil Caporaso
Journal:  J Natl Cancer Inst       Date:  2008-10-28       Impact factor: 13.506

9.  Genome-wide association studies in cancer--current and future directions.

Authors:  Charles C Chung; Wagner C S Magalhaes; Jesus Gonzalez-Bosquet; Stephen J Chanock
Journal:  Carcinogenesis       Date:  2009-11-11       Impact factor: 4.944

10.  A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33.

Authors:  Hemang Parikh; Zuoming Deng; Meredith Yeager; Joseph Boland; Casey Matthews; Jinping Jia; Irene Collins; Ariel White; Laura Burdett; Amy Hutchinson; Liqun Qi; Jennifer A Bacior; Victor Lonsberry; Matthew J Rodesch; Jeffrey A Jeddeloh; Thomas J Albert; Heather A Halvensleben; Timothy T Harkins; Jiyoung Ahn; Sonja I Berndt; Nilanjan Chatterjee; Robert Hoover; Gilles Thomas; David J Hunter; Richard B Hayes; Stephen J Chanock; Laufey Amundadottir
Journal:  Hum Genet       Date:  2009-10-13       Impact factor: 4.132
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.